申请人:Millennium Pharmaceuticals, Inc.
公开号:US20130165483A1
公开(公告)日:2013-06-27
This invention provides compounds of formula IB:
wherein HY, R
1
, R
2
, R
3
, R
15
, G
5
, G
6
, G
7
, G
8
, and G
9
are as described in the specification. The compounds are inhibitors of VPS34 and/or PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
本发明提供了式IB的化合物:其中HY,R1,R2,R3,R15,G5,G6,G7,G8和G9如规范中所述。这些化合物是VPS34和/或PI3K的抑制剂,因此对于治疗增殖性,炎症性或心血管疾病有用。